跳至主要内容
临床试验/JPRN-UMIN000051670
JPRN-UMIN000051670尚未招募Unknown

A multicenter retrospective observational study to evaluate the efficacy and safety of durvalumab following concurrent chemoradiotherapy for stage III non-small cell lung cancer harboring EGFR mutation (NEJ063 study) - NEJ063 study

Tohoku University Hospital0 个研究点目标入组 300 人开始时间: 2023年7月20日最近更新:
适应症

试验速览

阶段
Unknown
状态
尚未招募
入组人数
300

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
ot applicable 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • (1) Cases treated with sequential combination of chemotherapy and radiotherapy. (2)Cases that the physician judged to be inappropriate for reasons such as inability to collect the information necessary to fill out the CRF.

研究者

相似试验

A multicenter retrospective observational study to... | 临床试验